+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Albumin: Global Strategic Business Report

  • PDF Icon

    Report

  • 182 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5030537

Global Albumin Market to Reach $1.2 Billion by 2030

The global market for Albumin estimated at US$872.6 Million in the year 2022, is projected to reach a revised size of US$1.2 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Human Serum Albumin, one of the segments analyzed in the report, is projected to record 3.3% CAGR and reach US$902.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Recombinant Albumin segment is readjusted to a revised 5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $230.8 Million, While China is Forecast to Grow at 6.4% CAGR

The Albumin market in the U.S. is estimated at US$230.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$260.8 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.1% and 2.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.

Select Competitors (Total 14 Featured) -

  • Albumedix Ltd.
  • Albumin Bioscience
  • Biotest AG
  • CSL Behring
  • Grifols International SA
  • HiMedia Laboratories Pvt. Ltd.
  • InVitria
  • Medxbio Pte. Ltd.
  • MilliporeSigma
  • Octapharma AG
  • RayBiotech, Inc.
  • Seracare Life Sciences, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and the publisher's Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Albumin

What is the estimated value of the Global Market for Albumin?

The Global Market for Albumin was estimated to be valued at $872.6 Million in 2022.

What is the growth rate of the Global Market for Albumin?

The growth rate of the Global Market for Albumin is 4.1%, with an estimated value of $1200 Million by 2030.

What is the forecasted size of the Global Market for Albumin?

The Global Market for Albumin is estimated to be worth $1200 Million by 2030.

Who are the key companies in the Global Market for Albumin?

Key companies in the Global Market for Albumin include Albumedix Ltd., Albumin Bioscience, Biotest AG, CSL Behring, Grifols International SA, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte. Ltd., MilliporeSigma and Octapharma AG.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Albumin - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Albumin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Human Serum Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Human Serum Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Human Serum Albumin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Recombinant Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Recombinant Albumin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Recombinant Albumin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Pharmaceutical & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Pharmaceutical & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Albumin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: USA Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: USA 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 23: USA Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Canada 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 29: Canada Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Japan Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Japan 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 35: Japan Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: China Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: China 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 41: China Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Albumin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 45: Europe Historic Review for Albumin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Europe 16-Year Perspective for Albumin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 47: Europe Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 53: France Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: France Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: France 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 59: Germany Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: Germany Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: Germany 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
  • Table 65: Italy Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Italy Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: Italy 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 71: UK Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: UK Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: UK 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
  • Table 77: Spain Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: Spain Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: Spain 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 80: Spain Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: Spain 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
  • Table 83: Russia Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Russia Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Russia 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 86: Russia Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Russia 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • Table 89: Rest of Europe Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Rest of Europe Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Rest of Europe 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Albumin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 96: Asia-Pacific Historic Review for Albumin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Asia-Pacific 16-Year Perspective for Albumin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Albumin by Product - Human Serum Albumin and Recombinant Albumin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Albumin by Product - Human Serum Albumin and Recombinant Albumin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Albumin by Product - Percentage Breakdown of Value Sales for Human Serum Albumin and Recombinant Albumin for the Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Albumin by End-Use - Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Albumin by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Industry, Research Institutes and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Albumin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Albumedix Ltd.
  • Albumin Bioscience
  • Biotest AG
  • CSL Behring
  • Grifols International SA
  • HiMedia Laboratories Pvt. Ltd.
  • InVitria
  • Medxbio Pte. Ltd.
  • MilliporeSigma
  • Octapharma AG
  • RayBiotech, Inc.
  • Seracare Life Sciences, Inc.